Pluto Bioinformatics

GSE156708: FBXO11 is a candidate tumor suppressor in the leukemic transformation of myelodysplastic syndrome

Bulk RNA sequencing

This experiment is assocaited with a publication defining a tumor supressor role of FBXO11 in the transformation of MDS. We observe decreased expression of FBXO11 is associated with transformation to secondary AML. SOURCE: John Crispino (zoul@northwestern.edu) - Northwestern University